SOFIA (Bulgaria), May 9 (SeeNews) – Pharmaceuticals company AstraZeneca plans to invest over 7.0 million levs ($4.9 million/3.6 million euro) in clinical trials in Bulgaria this year, the executive director of its local unit said.